Varex Imaging (NASDAQ:VREX) Updates Q1 Earnings Guidance

Varex Imaging (NASDAQ:VREX) issued an update on its first quarter earnings guidance on Tuesday morning. The company provided earnings per share (EPS) guidance of $(0.05)-$0.10 for the period, compared to the consensus estimate of $0.02. The company issued revenue guidance of $195-215 million, compared to the consensus revenue estimate of $186.50 million. Varex Imaging also updated its Q1 2025 guidance to -0.050-0.100 EPS.

Varex Imaging Stock Up 5.9 %

Shares of VREX opened at $15.42 on Thursday. The company has a debt-to-equity ratio of 0.67, a quick ratio of 1.89 and a current ratio of 3.34. Varex Imaging has a 52 week low of $10.19 and a 52 week high of $21.50. The stock has a market capitalization of $630.68 million, a price-to-earnings ratio of -13.18 and a beta of 0.53. The stock has a fifty day moving average of $12.50 and a 200-day moving average of $13.47.

Analyst Ratings Changes

Separately, B. Riley began coverage on Varex Imaging in a research note on Friday, August 23rd. They set a “buy” rating and a $21.00 price target on the stock.

About Varex Imaging

Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. The company operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers.